Biomedical Device News and Research

RSS

PRIME-XS open call for proposals

The PRIME-XS consortium is a strategic collaboration of research groups from twelve international institutes, leading in the field of proteomics. PRIME-XS provides an infrastructure of state-of-the-art proteomics technologies to the European biological and biomedical research community. PRIME-XS is providing open and competitive access to their proteomics instrumentation and expertise.

7 Jul 2011

Randox Drug Residues release newly improved Multi-Sulphonamide Testing Platform

Randox Drug Residues have released their newly improved Antimicrobial Array I. This comprehensive multiplex testing platform allows for the simultaneous detection of 15 of the most commonly abused sulphonamides in food production and agricultural industries.

From Randox Laboratories Ltd. 23 Jun 2011

BDC releases new technology to aid medical device industry with product design testing

Endovascular stents, stent grafts, and transcatheter heart valve (TAVI) devices provide enhanced methods for clinical treatment of cardiac and vascular disease. Further research and product development is currently ongoing worldwide to address complications associated with these devices.

15 Jun 2011

Practical solutions for translational science from Randox Laboratories

The sole purpose of translational science is to transfer scientific discoveries made in ‘basic research’ to clinical reality, to improve the health of individuals and reduce suffering.

From Randox Laboratories Ltd. 23 May 2011

Cellix expands European distribution network with Tebu-bio

Cellix are pleased to announce the signing of a distribution agreement with tebu-bio SAS. tebu-bio has a well-established pan-European presence, recognised by the international scientific community with local offices in France, Germany, Belgium, the Netherlands, Italy, Denmark, Portugal, Spain and the UK.

11 Apr 2011

Biotage introduces new system for microwave-assisted peptide synthesis

Biotage® (STO: BIOT), a supplier of tools and technology for medicinal, analytical and peptide chemistry, introduced the Biotage Initiator Peptide Workstation for manual microwave-assisted peptide synthesis. The Workstation utilizes a unique microwave peptide vial available in two sizes; 2-5 mL for 75-150 μmol scale or 10-20 mL for 250-500 μmol scale synthesis.

24 Mar 2011

Innoheart, genae enter strategic alliance to transform translational clinical research

Innoheart and genae today announced a shared vision on integrated research services, allowing the acceleration of clinical research and development of biomedical devices and therapies. The alliance will allow both organizations to drive new growth opportunities globally and transform translational clinical research, reducing costs and accelerating market entry for new biomedical devices and therapies.

2 Mar 2011

Improved brain-machine technologies

A new study published in the Dec 15 issue of The Journal of Neuroscience found that monkeys were able to move thought-controlled computer cursors more quickly and accurately when provided with additional sensory feedback.

19 Dec 2010

New experimental device could offer effective treatment option for people with swallowing disorders

In what might be one of the world's first medicinal body piercings, UC Davis Health System surgeons announced today that they have successfully implanted an experimental device in the throat of a man that will enable him to manually control his ability to swallow.

1 Dec 2010

Micell initiates enrollment in DESSOLVE I clinical trial of MiStent DES

Micell Technologies,™ Inc. today announced it has enrolled at Mercy Hospital in Auckland, New Zealand, the first patient in DESSOLVE I (DES with Sirolimus and a bioabsorbable pOLymer for the treatment of patients with de noVo lEsions in the native coronary arteries), a first-in-human clinical trial of the company's investigational MiStent™ Drug Eluting Coronary Stent System (MiStent DES).

29 Nov 2010

Discovery Labs reports net operating loss of $6.2 million for third quarter 2010

Discovery Laboratories, Inc., a biotechnology company developing its novel, synthetic, peptide-containing surfactant and related aerosolization technologies as first in class therapies for severe respiratory diseases, today provides an update on key pipeline and business initiatives and a financial update for the third quarter ended September 30, 2010.

9 Nov 2010

Incept completes first U.S. human clinical trial of SMART Start Embryo Culture System

Incept BioSystems, Inc. a privately-held biomedical device company using patented, microfluidic technology developed at the University of Michigan, announced today the completion of the first U.S. human clinical trial of its proprietary, SMART Start Embryo Culture System, and the recent submission of a 510(k) application to the U.S. Food & Drug Administration.

13 Oct 2010

$Osseon receives second patent NOA for spinal vertebral compression fracture technology$

Osseon receives second patent NOA for spinal vertebral compression fracture technology

Osseon Therapeutics, Inc., a biomedical device company based in Santa Rosa, California, received its second patent Notice of Allowance (NOA) for its spinal vertebral compression fracture (VCF) technology.

5 Oct 2010

$Osseon receives notice of allowance for spinal vertebral compression fracture technology$

Osseon receives notice of allowance for spinal vertebral compression fracture technology

Osseon Therapeutics, Inc., a biomedical device company based in Santa Rosa, California, today received a notice of allowance for its spinal vertebral compression fracture (VCF) technology. The company which was started in 2006 has thirteen additional patent applications pending in the United States and throughout the world for related spinal therapies and devices. The lead inventor for this inaugural patent is Dr. Y. King Liu, one of three founders of Osseon.

15 Jul 2010

Artificial heart to be a reality soon, expect researchers

There is good news for heart patients waiting in line for a heart transplant. A team of researchers in Queensland, Malaysia, Germany and Japan are working on an artificial heart. They plan to try it first in sheep.

29 Apr 2010

Nuvon introduces IDM-MG 1000 portable solution for biomedical data collection

San Francisco-based Nuvon, Inc. (www.nuvon.com), a provider of next generation BMDI (biomedical device interoperability) solutions, announces the introduction of the IDM-MG 1000, extending Nuvon’s biomedical device interoperability capabilities by providing the first truly mobile and portable solution to collect and present critical biomedical device data anywhere.

2 Mar 2010

Incept BioSystems commences human clinical trial of its SMART Embryo Culture System

Incept BioSystems, Inc., a privately-held biomedical device company using patented microfluidic technology developed at the University of Michigan, announced today that it has initiated the first U.S. human clinical trial of its proprietary SMART Embryo Culture System. The microscale SMART technology platform is designed to improve the in vitro manipulation, performance, and viability of embryos for the treatment of patients undergoing in vitro fertilization (IVF).

1 Oct 2009

Growth of biotechnology in LA depends on social cooperation

Stronger connections among businesses, universities and, most importantly, people are necessary if the biotechnology industry is going to survive and thrive in Los Angeles, according to a new study by Professor Steven Casper at Keck Graduate Institute (KGI).

17 Sep 2009

Camera-phone uses blood, saliva samples to diagnose disease

Researchers at the University of California, Berkeley, have developed a "prototype camera-phone mounted with a microscope" that can "magnify and photograph blood or saliva samples" for diagnosing diseases, the Canadian Press/Google.com reports.

22 Jul 2009

Medical use for waste television screens

Waste material from discarded televisions could be recycled and used in medicine, according to new research by scientists at the University of York.

13 Jul 2009